FiercePharma10 小时
AstraZeneca, Amgen's Tezspire scores in rhinosinusitis study
Six months after Amgen and AstraZeneca reported promising results for Tezspire (tezepelumab) as a potential treatment for ...
Battling Sinus Woes? Here’s How Seasonal Allergies Can Wreak Havoc and What You Can Do ...
Expert says, that by recognising the connection between seasonal changes, allergies, and sinus health, individuals can take ...
AstraZeneca/Amgen's Asthma Drug Aces Late-Stage Study In Patients With Chronic Rhinosinusitis
AstraZeneca and Amgen's Phase 3 trial data shows Tezspire significantly reduces nasal polyps and congestion in patients with chronic rhinosinusitis with nasal polyps.
Tezspire succeeds in chronic rhinosinusitis; Gilead writes down Trodelvy value
AstraZeneca and Amgen's drug could have a new use after positive Phase 3 study results. Elsewhere, Jazz set new plans for a ...
Woman's World on MSN4 小时
Dealing with a Blocked Nostril? Here's How to Clear It Fast!
Have you ever been frustrated by one side of your nose feeling completely blocked while the other is clear? As annoying as it ...
EuropaWire10 小时
Tezspire Shows Promise in Reducing Nasal Polyp Symptoms in Phase III Trial for Chronic ...
(IN BRIEF) A Phase III trial of Tezspire (tezepelumab) by AstraZeneca and Amgen has shown significant benefits for patients ...